MR编号 | DK/H/3243/001 |
---|
药品名称 | Cabazitaxel Fresenius Kabi |
---|
活性成分 | |
---|
剂型 | Concentrate for solution for infusion |
---|
上市许可持有人 | Fresenius Kabi AB
Rapsgatan 7
751 74 Uppsala
Sweden |
---|
参考成员国 - 产品名称 | Denmark (DK) Cabazitaxel Fresenius Kabi |
---|
互认成员国 - 产品名称 | - Netherlands (NL)
Cabazitaxel Fresenius Kabi 20 mg/ml, Concentraat voor oplossing voor infusie - Poland (PL)
Cabazitaxel Fresenius Kabi - Croatia (HR)
- Luxembourg (LU)
- Latvia (LV)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Lithuania (LT)
Cabazitaxel Fresenius Kabi 20 mg/ml koncentratas infuziniam tirpalui - Austria (AT)
- Estonia (EE)
- France (FR)
- Hungary (HU)
Cabazitaxel Fresenius Kabi 20 mg/ml koncentrátum oldatos infúzióhoz - Spain (ES)
- Bulgaria (BG)
Cabazitaxel Fresenius Kabi - Portugal (PT)
- Cyprus (CY)
CABAZITAXEL FRESENIUS KABI 20MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION - Italy (IT)
- Czechia (CZ)
Cabazitaxel Fresenius Kabi - Greece (GR)
- Romania (RO)
- Sweden (SE)
- Slovakia (SK)
- Germany (DE)
- Norway (NO)
- Slovenia (SI)
- Belgium (BE)
- Finland (FI)
- Malta (MT)
Cabazitaxel Fresenius Kabi 20 mg/ml concentrate for solution for infusion
|
---|
许可日期 | 2022/08/03 |
---|
最近更新日期 | 2025/02/04 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|